What is ADMA Biologics's cash ratio?

ADMA Biologics (ADMA) reported cash ratio of 1.9× in Q1 2026.

How has ADMA Biologics's cash ratio changed year-over-year?

ADMA Biologics's cash ratio increased by 40.3% year-over-year, from 1.3× to 1.9×.

What is the long-term trend for ADMA Biologics's cash ratio?

Over 5 years (2020 to 2025), ADMA Biologics's cash ratio has grown at a -14.8% compound annual growth rate (CAGR), from 2.8× to 1.3×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

ADMA Biologics ADMA Cash ratio

Cash ratio at other companies

AbCellera Biologics Inc.ABCL

2.2×-0.3×

AnaptysBio, Inc.ANAB

6×+3.7×

ZymeworksZYME

6.9×+5.7×

Bio-Rad LaboratoriesBIO

0.6×-0.5×

Apogee Therapeutics, Inc.APGE

13.7×+10.5×

Quest DiagnosticsDGX

0.2×0.0×

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Calculated from ADMA Biologics’s reported figures.

cash and equivalents/total current liabilities=1.9×

Based on the most recent quarter.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's cash ratio?: ADMA Biologics (ADMA) reported cash ratio of 1.9× in Q1 2026.
How has ADMA Biologics's cash ratio changed year-over-year?: ADMA Biologics's cash ratio increased by 40.3% year-over-year, from 1.3× to 1.9×.
What is the long-term trend for ADMA Biologics's cash ratio?: Over 5 years (2020 to 2025), ADMA Biologics's cash ratio has grown at a -14.8% compound annual growth rate (CAGR), from 2.8× to 1.3×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.